Moderna Shares Spike After Company Says Its Covid Booster Increases Antibody Levels Against Omicron

Posted byAmanda Breen Leave a comment on Moderna Shares Spike After Company Says Its Covid Booster Increases Antibody Levels Against Omicron

The company also has plans to continue the development of a booster specifically targeting Omicron, which is expected to enter clinical trials in early 2022. 

Leave a comment

Your email address will not be published. Required fields are marked *